I-CERAM (EPA:ALICR) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
I-CERAM

BRIEF

published on 11/07/2024 at 18:41, 13 days 15 hours ago

Pilot Study on Antibiotic-Loaded Ceramic Implant Launched

Innovation Clinical Study Cardiac Surgery Ceramic Implant Mediastinitis
REGULATED PRESS RELEASE

published on 11/07/2024 at 18:36, 13 days 15 hours ago

I.CERAM - Professor Pascal Leprince, Head of the Cardiac Surgery Department at the Pitié-Salpêtrière Hospital in Paris, has agreed to set up a pilot clinical
I.Ceram to conduct pilot clinical study on antibiotic-loaded Porous Ceramic Sternal Stabilisation Implant at Pitié-Salpêtrière Hospital in Paris with Professor Pascal Leprince. Implant aims to prevent bacterial contamination and stabilize chest walls

I.Ceram Clinical Study Antibiotic-loaded Implant Porous Ceramic Chest Wall Stabilization
BRIEF

published on 11/07/2024 at 18:15, 13 days 16 hours ago

Implementation of a clinical study at I.CERAM

Clinical Study Ceramic Implant Sternotomy Post-operative Infection Heart Surgery
BRIEF

published on 10/31/2024 at 20:31, 20 days 14 hours ago

Review of the First Half of 2024 for I.CERAM

Financial Results Turnover Restructuring Plan Judicial Recovery Extension Of Observation
BRIEF

published on 09/11/2024 at 17:58, 2 months 9 days ago

I.CERAM Combined General Meeting on September 26, 2024

Shareholders I.Ceram General Assembly Preparatory Documents Summons
BRIEF

published on 08/06/2024 at 19:50, 3 months 14 days ago

I.CERAM: Final 2023 accounts and publication of the Universal Registration Document

I.Ceram Universal Registration Document Legal Redress 2023 Accounts MDR Regulations
BRIEF

published on 06/25/2024 at 20:09, 4 months 25 days ago

I.CERAM - Extension to September 30, 2024 of the deadline for holding the General Meeting

I.Ceram Extension Annual Accounts General Assembly The Commercial Court
BRIEF

published on 06/06/2024 at 22:18, 5 months 14 days ago

I.CERAM 2023 annual results: a year marked by challenges

Financial Performance I.Ceram Orthopedic Implants 2023 Financial Results Legal Redress
BRIEF

published on 04/30/2024 at 18:05, 6 months 20 days ago

I.CERAM Postpones the Publication of its 2023 Results and the Universal Registration Document

I.Ceram 2023 Annual Results Universal Registration Document Legal Redress Postponement Of Publication
BRIEF

published on 04/24/2024 at 20:03, 6 months 26 days ago

I.Ceram in Judicial Reorganization to Safeguard its Future

I.Ceram Regulation Medical Innovation Legal Redress Bioceramic

Accesswire

Published on 11/21/2024 at 10:03, 31 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 34 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 34 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 59 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 9 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 29 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 32 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 34 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 34 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 33 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 36 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 14 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 49 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 49 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE